Ignore Big Pharma's Faux 'Facts,' HHS Says In Kickback Clash
By Jeff Overley · April 3, 2023, 10:47 PM EDT
Drugmakers are skewing basic issues in closely watched litigation over health care kickbacks by presenting "irrelevant material" and "slanted characterizations" as undisputed facts, federal health care officials told a Virginia federal...
To view the full article, register now.